Drug intelligence / Profile preview

Hyruan Plus

Development stage
Phase 4
Lead developer
LG Chem
Administration
Intra-articular Injection
01

Overview

Hyruan Plus is a pharmaceutical drug containing high molecular weight sodium hyaluronate, primarily indicated for the treatment of osteoarthritis, particularly in the knee and shoulder joints. It functions as a viscoelastic supplement, aiming to restore the lubricating and shock-absorbing properties of synovial fluid within the affected joints. This action helps to reduce friction, alleviate pain and inflammation, and improve overall joint mobility. Additionally, it has been noted for use as a surgical aid in various ophthalmic procedures, including cataract extraction, intraocular implantation, corneal transplant, glaucoma filtration, and retinal attachment surgery. The drug is administered via intra-articular injection.

Brand names
Hyruan Plus
02

Targets

CD44 (CD44 antigen)STAB2 (Stabilin-2)ICAM1 (Intercellular Adhesion Molecule 1)LYVE1 (Lymphatic vessel endothelial hyaluronic acid receptor 1)

Beyond the preview

Go deeper on Hyruan Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyruan Plus.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call